K

KMPharmaceutical Co Ltd
KOSDAQ:225430

Watchlist Manager
KMPharmaceutical Co Ltd
KOSDAQ:225430
Watchlist
Price: 581 KRW 0.87% Market Closed
Market Cap: ₩16.2B

KMPharmaceutical Co Ltd
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

KMPharmaceutical Co Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
K
KMPharmaceutical Co Ltd
KOSDAQ:225430
Total Current Liabilities
₩11.5B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
N/A
AmorePacific Corp
KRX:090430
Total Current Liabilities
₩1T
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
2%
Amorepacific Group
KRX:002790
Total Current Liabilities
₩1.1T
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
2%
Cosmax Inc
KRX:192820
Total Current Liabilities
₩1.3T
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
17%
LG H&H Co Ltd
KRX:051900
Total Current Liabilities
₩1T
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Kolmar Korea Co Ltd
KRX:161890
Total Current Liabilities
₩1.4T
CAGR 3-Years
21%
CAGR 5-Years
23%
CAGR 10-Years
29%
No Stocks Found

KMPharmaceutical Co Ltd
Glance View

Market Cap
16.2B KRW
Industry
Consumer products

KMPHARMACEUTICAL Co., Ltd. engages in the development and sale of oral health products. The company is headquartered in Pyeongtaek, Gyeonggi-Do. The company went IPO on 2015-10-08. Oral hygiene products include toothpaste, toothbrush and goggles. Cosmetic products consist of shampoo, body wash, sun cream, moisturizing cream, as well as lip balm and others. The firm distributes its products within domestic market and to overseas markets including North America, South America, Europe, China, Malaysia, Singapore, Vietnam and Australia.

Intrinsic Value
536.06 KRW
Overvaluation 8%
Intrinsic Value
Price
K

See Also

What is KMPharmaceutical Co Ltd's Total Current Liabilities?
Total Current Liabilities
11.5B KRW

Based on the financial report for Sep 30, 2025, KMPharmaceutical Co Ltd's Total Current Liabilities amounts to 11.5B KRW.

What is KMPharmaceutical Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
21%

Over the last year, the Total Current Liabilities growth was 30%. The average annual Total Current Liabilities growth rates for KMPharmaceutical Co Ltd have been 17% over the past three years , 21% over the past five years .

Back to Top